Study of ADCT-301 in Patients With Selected Advanced Solid Tumors

Clinical trial NCT03621982 · TERMINATED

Trial details

NCT number: NCT03621982
Sponsor: ADC Therapeutics S.A.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Head and Neck Cancer Squamous Cell Carcinoma Non-small Cell Lung Cancer Gastric Cancer Esophageal Cancer Pancreas Cancer Bladder Cancer Renal Cell Carcinoma Melanoma Triple-negative Breast Cancer Ovarian Cancer Colo-rectal Cancer Fallopian Tube Cancer

Start date: 2018-11-09
Primary completion: 2022-12-14
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.